Biological Assets - Changes in Carrying Value of Biological Assets (Details) - CAD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
Reconciliation of changes in biological assets [abstract] | ||
Balance, beginning of period | $ 42,774 | $ 22,690 |
Production costs capitalized | 116,915 | 85,766 |
Sale of biological assets | (58,038) | (39,218) |
Change in inventory provision | (246) | (1,126) |
Foreign currency translation | 29 | (3) |
Changes in fair value less cost to sell due to biological transformation | 175,361 | 134,588 |
Transferred to inventory upon harvest | (225,627) | (159,923) |
Balance, end of period | $ 51,168 | $ 42,774 |
X | ||||||||||
- Definition The amount of additions to biological assets, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Biological assets] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount of living animals or plants recognised as assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The decrease in biological assets due to the detachment of produce from the assets or the cessation of the assets' life processes. [Refer: Biological assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The decrease in biological assets resulting from disposals. [Refer: Biological assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The gains (losses) arising from changes in fair value less costs to sell of biological assets due to physical changes. [Refer: Biological assets] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The amount of impairment loss recognised in profit or loss for biological assets. [Refer: Impairment loss recognised in profit or loss; Biological assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The increase (decrease) in biological assets resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Biological assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|